Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-01

Clinical Trial Update: Comparison of Two Insulin Aspart Formulations in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study comparing two insulin aspart formulations in healthy volunteers; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • insulin aspart formulation A (insulin aspart)
  • insulin aspart formulation B (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED